Modeling the Influence of <i>CYP2C9</i> and <i>ABCB1</i> Gene Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Losartan
<b>Background/Objectives:</b> Hypertension is a pathological condition characterized by elevated systolic and/or diastolic blood pressure. A range of pharmacotherapeutic agents are available to treat this condition and prevent complications, including the angiotensin II AT1-receptor bloc...
Saved in:
| Main Authors: | Dmitry Babaev, Elena Kutumova, Fedor Kolpakov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mathematical modeling of pharmacokinetics and pharmacodynamics of losartan in relation to CYP2C9 allele variants
by: Dmitry Babaev, et al.
Published: (2025-05-01) -
<i>ABCB1</i> Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
by: Natasa Djordjevic, et al.
Published: (2025-01-01) -
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study
by: Avner Sandhu, et al.
Published: (2025-04-01) -
Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders
by: Yingying Xin, et al.
Published: (2025-07-01) -
Molecular Ancestry Across Allelic Variants of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Mexican-Mestizo DMT2 Patients
by: Adiel Ortega-Ayala, et al.
Published: (2025-05-01)